| Depletions > Psychotherapeutic Medications, ... |  |
| Psychotherapeutic Medications | ||
| Thioxanthene Derivatives | ||
|
| ||
 | ||
| Depletions | ||
| Coenzyme Q10 | ||
|
A deficiency of the antioxidant coenzyme Q10 may be associated with long-term conditions including heart disease and high blood pressure. Symptoms of deficiency include gingivitis, and weakened immune function. | ||
| ||
| Vitamin B2 (Riboflavin) | ||
|
Symptoms of vitamin B2 deficiency may include cracks at the corners of the mouth, inflammation of the skin, growth retardation, and impaired wound healing. | ||
| ||
| Editorial Note | ||
| ||
| Supporting Research | ||
|
Chan A, Reichmann H, Kogel A, et al. Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy. J Neurol. 1998;245(10):681 Fauci, A. ed. et. al. Harrison's Principles of Internal Medicine. Fourteenth Edition. New York, Mc-Graw-Hill Companies Health Professional Division, 1998. Folkers K, Morita M, McRee J Jr. The activities of coenzyme Q10 and vitamin B6 for immune responses. Biochem Biophys Res Commun. 1993; 28(19391):88. Folkers, K. Basic chemical research on coenzyme Q-10 and integrated clinical research on therapy of diseases, in Coenzyme Q, G. Lenaz, ed., John Wiley & Sons, 1985. International Life Sciences Institute, Present Knowledge in Nutrition. Seventh Edition. Washington, DC, ILSI Press, 1996. Kamikawa T, Kobayashi A, Yamashita T, et al. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol. 1985;56(4):247 Munkholm H, Hansen HH, Rasmussen K. Coenzyme Q10 treatment in serious heart failure. Biofactors.1999;9(2) Nakamura R, Littarru GP, Folkers R, et al. Study of CoQ10-enzymes in gingiva from patients with periodontal disease and evidence for a deficiency of coenzyme Q10. Proc Natl Acad SciUSA. 1974;71(4):1456-1460. National Research Council, Recommended Dietary Allowances. Tenth Edition. Washington, DC, National Academy Press, 1989. Pinto, J. et al. Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine and amitriptyline. J Clin Invest. 1981;67:1, 500. Singh RB, Niaz MA, Rastogi SS, et al. Effect of hydrosoluble coenzyme Q10 on blood pressure and insulin resistance in hypertensive patients with coronary heart disease. J Hum Hypertens. 1999;13(3):203 Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther. 1998;12(4):347-353. | ||
| ||
| Review Date: October 2000 | ||
| Reviewed By:
All depletions monographs have been reviewed by a
team of experts including
Derrick M. DeSilva, Jr., MD, Raritan Bay Medical Center, Perth Amboy, NJ;
Jacqueline A. Hart, MD, Department of Internal Medicine, Newton-Wellesley
Hospital, Harvard University and Senior Medical Editor, A.D.A.M., Inc., Boston,
MA; John Hinze, PharmD, NMD, Woodbine, IA; Ruth Marlin, MD, Medical Director and
Director of Medical Education, Preventive Medicine Research Institute,
Sausalito, CA; Brian T Sanderoff, PD, BS in Pharmacy, Clinical Assistant
Professor, University of Maryland School of Pharmacy; President, Your
Prescription for Health, Owings Mills, MD; Leonard Wisneski, MD, FACP, George
Washington University, Rockville, MD; Ira Zunin, MD, MPH, MBA, President and
Chairman, Hawaii State Consortium for Integrative Medicine, Honolulu,
HI. | ||
|
|
|
|